Hospital-onset clostridium difficile infection rates in persons with cancer or Hematopoietic stem cell transplant: A C3IC network report

Infection Control and Hospital Epidemiology

Volumn 33, Issue 11, 2012, Pages 1162-1164

  Kamboj, Mini ^a   Son, Crystal ^a   Cantu, Sherry ^e   Chemaly, Roy F ^e   Dickman, Jeanne ^g   Dubberke, Erik ^f,l   Engles, Lisa ⁱ   Lafferty, Theresa ^b   Liddell, Gale ^c   Lesperance, Mary Ellen ⁱ   Mangino, Julie E ^g   Martin, Stacy ^d   Mayfield, Jennie ^f   Mehta, Sapna A ^k   O'Rourke, Susan ^h   Perego, Cheryl S ^e   Taplitz, Randy ^j   Eagan, Janet ^a   Sepkowitz, Kent A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f BARNES JEWISH HOSPITAL   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h DANA FARBER CANCER INSTITUTE   (United States)

ⁱ KARMANOS CANCER INSTITUTE   (United States)

^j Thornton Hospital   (United States)

^k NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^l WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CLOSTRIDIUM DIFFICILE INFECTION; DISEASE SURVEILLANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA; LYMPHOMA; MULTICENTER STUDY; NEOPLASM; SOLID TUMOR; UNITED STATES;

CANCER CARE FACILITIES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; HEALTH CARE SURVEYS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS; UNITED STATES;

EID: 84867465834     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/668023     Document Type: Article

References (13)

1. American Cancer Society. http://www.cancer.org/Research /CancerFactsFigures/CancerFactsFigures/cancer-facts-figures-2011.
2. Anand A, Glatt AE. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 1993; 17(1):109-113.
3. Gorschluter M, Glasmacher A, Hahn C, et al. Clostridiumdifficile infection in patients with neutropenia. Clin Infect Dis 2001;33(6): 786-791.
4. Loo VG, Poirier L, Miller MA, et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 2005; 353(23):2442-2449.
5. Bobak D, Arfons LM, Creger RJ, Lazarus HM. Clostridium difficile-associated disease in human stem cell transplant recipients: coming epidemic or false alarm? Bone Marrow Transplantation 2008;42(11):705-713.
6. McDonald LC, Coignard B, Dubberke E, et al. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol 2007;28(2):140-145.
7. New York State Department of Health. http://www.health.ny.gov/statistics/facilities/hospital/hospital_acquired_infections/2010/docs/hospital_acquired_infection.pdf.
8. California Department of Public Health. http://www.cdph.ca.gov/programs/hai/Pages/CDI-Report.aspx.
9. Ohio Department of Public Health. http://www.odh.ohio.gov /~/media/ODH/ASSETS/Files/news/cdifffinalreport.ashx.
10. Vital signs: preventing Clostridium difficile infections. MMWR Morb Mortal Wkly Rep 2012;61:157-162.
11. Deshpande A, Pasupuleti V, Rolston DD, et al. Diagnostic accuracy of real-time polymerase chain reaction in detection of Clostridium difficile in the stool samples of patients with suspected Clostridium difficile infection: a meta-analysis. Clin Infect Dis 2011;53(7):e81-e90.
12. Fong KS, Fatica C, Hall G, et al. Impact of PCR testing for Clostridium difficile on incident rates and potential on public reporting: is the playing field level? Infect Control Hosp Epidemiol 2011;32(9):932-933.
13. Kaltsas A, Simon M, Unruh LH, et al. Clinical and laboratory characteristics of Clostridium difficile infection in patients with discordant diagnostic test results. J Clinical Microbiol 2012:50(4): 1303-1307.